QR-Code

Interchangeability of CSF and PET to identify Alzheimer's disease pathology

Abstract INTRODUCTION Establishing interchangeability between cerebrospinal fluid (CSF) and positron emission tomography (PET) for patient identification may improve access to Alzheimer's disease (AD) therapies. METHODS Alzheimer's Disease Neuroimaging Initiative participants with mild cognitive imp...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Samantha C. Burnham, Anupa K. Arora, Leonardo Iaccarino, Ian Kennedy, Vikas Kotari, Sameera R. Wijayawardana, Leslie M. Shaw, Natalya Benina, Ming Lu, Michael J. Pontecorvo, Frances‐Catherine Quevenco, Jian Wang, Alzheimer's Disease Neuroimaging Initiative
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wiley 2026-04-01
Schriftenreihe:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Schlagworte:
Alzheimer's disease diagnosis
AD pathology
Alzheimer's disease
amyloid beta
biomarker
concordance analysis
Online-Zugang:https://doi.org/10.1002/dad2.70288
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge